Valuation (72%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 13.84 | 15.32 |
| PEG Ratio (TTM) | 0.14 | -0.58 |
| P/S Ratio (TTM) | 0.65 | 0.84 |
| P/B Ratio (TTM) | 1.31 | 1.29 |
| P/FCF Ratio (TTM) | 12.15 | 5.00 |
| Price to 5YR AVG Earnings Ratio | 51.15 | 7.54 |
| Price to 5YR AVG FCF Ratio | 8.07 | 8.15 |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 5.91% | 5.71% |
| ROE (TTM) | 9.69% | 8.60% |
| Net Profit Margin (TTM) | 5.04% | 5.73% |
| ROIC 5YR AVG | 11.75% | 20.47% |
Growth (85%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 33.55% | 55.90% | 23.41% |
| Revenue | 9.61% | -0.60% | 0.54% |
| Net Income | 33.78% | 57.66% | 23.53% |
| Cash Flow | 63.01% | 146.76% | 80.35% |
Health (81%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.64 | 2.46 |
| Quick Ratio (TTM) | 1.59 | 1.41 |
| D/E Ratio (TTM) | 0.03 | 0.37 |
| Interest Coverage (TTM) | -59.68 | 29.05 |
| Piotroski F-Score | 7 | 6 |
| Altman Z-Score | 3.00 | 3.62 |
| LTL to 5YR AVG FCF | 0.06 | 2.78 |
| Shares Outstanding Growth 5YR AVG | 1.80% | -3.05% |